Christina M Annunziata Selected Research

Christina M Annunziata Research Topics

Disease

42	Neoplasms (Cancer) 06/2022 - 10/2006
29	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 11/2007
8	Carcinoma (Carcinomatosis) 06/2022 - 01/2017
4	Tics (Tic) 01/2022 - 02/2015
4	Disease Progression 01/2020 - 03/2016
4	Neutropenia 04/2019 - 05/2013
4	Carcinogenesis 12/2017 - 11/2012
4	Multiple Myeloma 12/2017 - 08/2007
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2020 - 01/2018
3	Thrombocytopenia (Thrombopenia) 04/2019 - 03/2017
3	Triple Negative Breast Neoplasms 01/2019 - 10/2017
3	Ovarian Epithelial Carcinoma 02/2016 - 11/2007
2	Breast Neoplasms (Breast Cancer) 05/2018 - 02/2010
2	Head and Neck Neoplasms (Head and Neck Cancer) 01/2018 - 01/2016
2	Squamous Cell Carcinoma of Head and Neck 01/2018 - 01/2016
2	Hematologic Neoplasms (Hematological Malignancy) 12/2017 - 03/2012
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 12/2017 - 03/2012
2	Fatigue 07/2017 - 05/2013
1	Aneuploidy (Aneuploid) 01/2022
1	Lactic Acidosis 12/2020
1	Li-Fraumeni Syndrome 12/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020
1	Infections 04/2019
1	Inflammation (Inflammations) 01/2019
1	Fibrosis (Cirrhosis) 05/2018
1	Neoplasm Metastasis (Metastasis) 05/2018
1	Experimental Melanoma 01/2018

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 12/2020 - 10/2006
9	olaparibIBA 01/2020 - 01/2014
8	Pharmaceutical PreparationsIBA 12/2020 - 03/2012
7	Biomarkers (Surrogate Marker)IBA 10/2020 - 06/2013
6	Monoclonal AntibodiesIBA 06/2022 - 02/2013
6	Carboplatin (JM8)FDA LinkGeneric 06/2021 - 06/2014
6	PlatinumIBA 01/2020 - 01/2014
6	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2020 - 02/2010
5	Small Interfering RNA (siRNA)IBA 01/2018 - 11/2012
5	Transcription Factors (Transcription Factor)IBA 01/2018 - 05/2010
4	Immunoglobulin G (IgG)IBA 06/2022 - 01/2017
4	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 09/2010
4	birinapantIBA 12/2020 - 01/2016
4	Phosphotransferases (Kinase)IBA 10/2020 - 05/2010
4	Bevacizumab (Avastin)FDA Link 10/2020 - 08/2008
4	InterferonsIBA 01/2019 - 01/2016
4	NF-kappa B (NF-kB)IBA 05/2018 - 08/2007
3	Complement System Proteins (Complement)IBA 06/2022 - 01/2017
3	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2020 - 11/2018
3	Sorafenib (BAY 43-9006)FDA Link 10/2020 - 08/2008
3	durvalumabIBA 01/2020 - 07/2017
3	Biological ProductsIBA 01/2020 - 05/2010
3	AntigensIBA 01/2020 - 01/2017
3	CytokinesIBA 01/2019 - 01/2016
3	Cisplatin (Platino)FDA LinkGeneric 03/2018 - 11/2007
2	Carcinoembryonic AntigenIBA 06/2022 - 04/2020
2	Disulfiram (Antabuse)FDA Link 01/2022 - 06/2020
2	CaspasesIBA 06/2021 - 12/2020
2	Paclitaxel (Taxol)FDA LinkGeneric 06/2021 - 11/2007
2	Immune Checkpoint InhibitorsIBA 01/2020 - 01/2019
2	Interferon-gamma (Interferon, gamma)IBA 01/2019 - 01/2016
2	B7-H1 AntigenIBA 01/2019 - 07/2017
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 01/2010
2	cediranib (AZD2171)IBA 01/2019 - 07/2017
2	Interferon-alpha (Interferon Alfa)IBA 01/2019 - 01/2016
2	Topotecan (Hycamtin)FDA LinkGeneric 03/2018 - 03/2015
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2018 - 02/2015
2	EnzymesIBA 12/2017 - 02/2013
2	Bortezomib (Velcade)FDA Link 12/2017 - 03/2012
2	Proteasome Endopeptidase Complex (Proteasome)IBA 12/2017 - 03/2012
2	Protein Isoforms (Isoforms)IBA 06/2015 - 11/2012
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2010 - 11/2007
1	Cell Adhesion MoleculesIBA 06/2022
1	Caspase 8 (Caspase-8)IBA 06/2021
1	Drug CombinationsIBA 12/2020
1	Docetaxel (Taxotere)FDA Link 12/2020
1	Metformin (Glucophage)FDA LinkGeneric 12/2020
1	Glucose (Dextrose)FDA LinkGeneric 12/2020
1	hydrogen sulfite (bisulfite)IBA 10/2020
1	Cell-Free Nucleic AcidsIBA 10/2020
1	RNA (Ribonucleic Acid)IBA 06/2020
1	salinomycinIBA 06/2020
1	CEACAM1 ProteinIBA 04/2020
1	LigandsIBA 04/2019
1	ALT-803IBA 04/2019
1	Interleukin-15 (Interleukin 15)IBA 04/2019
1	ChemokinesIBA 01/2019
1	avelumabIBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 05/2018
1	Lysophosphatidic Acid ReceptorsIBA 05/2018
1	ParaffinIBA 03/2018
1	Topoisomerase I InhibitorsIBA 03/2018
1	Formaldehyde (Formol)FDA Link 03/2018
1	TNF Receptor-Associated Factor 3IBA 01/2018
1	prexasertibIBA 01/2018
1	itaconic acidIBA 01/2018
1	taxaneIBA 01/2018

Therapy/Procedure

18	Therapeutics 01/2020 - 10/2006
14	Drug Therapy (Chemotherapy) 06/2021 - 04/2008
4	Immunotherapy 06/2022 - 01/2016
2	Radiotherapy 12/2020 - 07/2020
1	Cytoreduction Surgical Procedures 01/2020